1 recruiting, 1 terminated. 2 Phase 4.
| Phase | Trials | Status |
|---|---|---|
| Phase 4 | 2 | Recruiting 1, Terminated 1 |
Follow Cardiovascular: new trials by email Literature Review of Cardiovascular trials Research Report on Cardiovascular
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Effects of Donor-recipient Sex-matched Blood Transfusion on Patient Outcomes Sex-mismatched red blood cell transfusions, Sex-matched red blood cell transfusions - Red Blood Cell Transfusions, Sex Differences | Phase 4 | Recruiting | Michelle Zeller | 11082 | 2025-09-11 | 2026-03-12 |
| Frequent, Low-Dose Erythropoietin A Mechanistic Approach to Mitigate Adverse Cardiovascular Effects of Erythropoietin Low dose erythropoietin, High dose erythropoietin - Anemia, CKD | Phase 4 | Terminated | VA Office of Research and Development | 5 | 2017-11-02 | 2020-08-13 |
Anemia (1) · Atherosclerosis (1)
Arterial Occlusive Diseases (1) · Arteriosclerosis (1) · Cardiovascular Diseases (1) · Hematologic Diseases (1) · Hemic and Lymphatic Diseases (1) · Vascular Diseases (1)
Contraceptives, Oral (1) · Erythropoietin (1)
Michelle Zeller (1) · VA Office of Research and Development (1)
Canada (1) · United States (1)
Mark S. Segal, MD PhD (1) · Michelle Zeller, Doctor of Medicine (1)
I01CX001449 (1)